... from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Metastatic renal cell carcinoma Patient-reported outcomes FKSI Quality of life Renal cancer (RC) is not usually symptomatic until it reaches a considerable size and an advanced stage...

... inhibitors (ICIs) has been a mainstay treatment for metastatic renal cell carcinoma (mRCC), surgical metastasectomy (SM) for select patients is considered a feasible option in the current guideline [1]. Although no randomized clinical trial has demonstrated the survival benefit of SM, many observational...

... with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD). The scientific evidence about the efficacy and safety of nivolumab in these patients is scarce. We report three cases of mRCC patients with ESRD treated with second-line nivolumab therapy. They received both biweekly and monthly...

... and required thyroid hormone regulation with levothyroxine had prolonged PFS (11.1 vs. 3.5 months; p = 0.002) and OS (26.4 vs. 15.6 months; p = 0.02). Hypothyroidism was found to be a significant side effect of axitinib in patients with metastatic renal cell carcinoma (mRCC). Patients with hypothyroidism had...

.... Metastasis Hypogonadism Testosterone deficiency Fatigue syndrome Metastatic renal cell carcinoma Targeted therapy Renal cell carcinoma (RCC) accounts for 2-3% of adult malignancies and is the third most common urologic tumor in the European Union [ 1,2 ]. For localized, early-stage tumors...

...Bernhard Ralla; Barbara Erber; Irena Goranova; Amelie Klooker; Andreas Maxeiner; Stefan Hinz; Carsten Kempkensteffen; Ahmed Magheli; Kurt Miller; Jonas Busch Objectives: Current evidence of sequence-targeted therapy (TT) for patients with metastatic renal cell carcinoma (mRCC) beyond fourth-line...

... nephrectomy, describing technical difficulties, safety and feasibility. Patients and Methods: We compared measurable surgical parameters and perioperative complications in 22 patients with metastatic renal cell carcinoma (mRCC) undergoing CRN after neoadjuvant sunitinib, with 28 patients who underwent open...

...Timur Hasan Kuru; Johannes Huber; Gencay Hatiboglu; Nina Wagener; Sascha Pahernik; Boris Hadaschik; Markus Hohenfellner Purpose: To report our experience with temsirolimus in 2nd-, 3rd- and 4th-line therapy for patients with metastatic renal cell carcinoma (mRCC). Patients and Methods: In our...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Metastatic renal cell carcinoma Interleukin 2 Lymphokine-activated killer cells Prostaglandin E 2 Peripheral blood mononuclear cell activity Immune status Cytokine...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Tyrosine kinase inhibitor Metastatic renal cell carcinoma Toxic dermatolysis Amputation Urologia Internationalis...

...Deniz Demirci; Atila Tatlışen; Oğuz Ekmekçioğlu; Nevzat Özcan; Reşat Kaya Introduction: We evaluated the results and effects of radical nephrectomy followed by immunochemotherapy and embolization alone on the survival of patients with metastatic renal cell carcinoma. Patients and Methods: The study...

... for such an approach. Patients and Methods: A retrospective analysis of 57 patients who received interleukin-2, interferon-α, and 5-fluorouracil immunochemotherapy for metastatic renal cell carcinoma was conducted. Before undergoing immunochemotherapy, 20 of the 57 patients had received metastatectomy along...

..., instructions or products referred to in the content or advertisements. Metastatic renal cell carcinoma Sphenoidal sinus metastasis Paranasal sinus metastasis Urologia Internationalis Case Report Urol Int 2004;73:285 286 DOI: 10.1159/000080845 Diplopia An Unusual Primary Manifestation of Metastatic...